Entera Bio Ltd.
ENTX
$1.22
$0.021.67%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -2.72% | -17.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 16.34% | -6.57% | |||
| Operating Income | -16.34% | 6.57% | |||
| Income Before Tax | -16.21% | 5.75% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -16.21% | 5.75% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -16.21% | 5.75% | |||
| EBIT | -16.34% | 6.57% | |||
| EBITDA | -16.38% | 6.56% | |||
| EPS Basic | -15.05% | 6.18% | |||
| Normalized Basic EPS | -15.04% | 6.12% | |||
| EPS Diluted | -15.05% | 6.18% | |||
| Normalized Diluted EPS | -15.04% | 6.12% | |||
| Average Basic Shares Outstanding | 1.02% | 0.39% | |||
| Average Diluted Shares Outstanding | 1.02% | 0.39% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||